Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients
暂无分享,去创建一个
T. Butler | K. Kudsk | W. Lesslauer | E. Abraham | P. Laterre | W. Zimmerli | M. Reynaert | J. Garbino | D. Lew | P. van der Auwera | T. Dugernier | B. Margolis | M. Salgo | S. Pingleton | A. Burdeska | A. Leighton | M. Modi | Sharon Cooper | P. Anderson